Bli medlem
Bli medlem

Du är här

2020-08-10

Redsense Medical AB announces approval by University Health Network in Toronto, Canada , to conduct a follow up study of the Redsense Clamp prototype

Redsense has previously conducted a usability study on Redsense Clamp together with the UHS. In October 2018, Redsense announced the completion of this study, where Canadian home dialysis patients used the Redsense blood leakage alarm together with Redsense Clamp and successfully demonstrated proof of concept. The follow up is projected to be initiated in the fall of 2020.

"This project is important to improve the patient safety of hemodialysis in general. We are now developing the product further, and we plan to have a new prototype ready in quarter three. We will then do a follow up study during the winter," says Redsense Medical's CEO Patrik Byhmer: "UHS's approval is the prerequisite and brings us one step closer towards faster and more reliable detection of blood leakage from venous needle dislodgement for all hemodialysis patients."

About Redsense Clamp
The Redsense Clamp product was introduced in 2018 and is currently under development. Redsense Clamp is an accessory to the company's blood leakage alarm NS enables the blood flow to be stopped automatically regardless of which dialysis machine is used. The purpose of Redsense Clamp is to enable the Redsense blood leakage alarm to offer the highest possible patient safety even when it is used together with a dialysis machine without a direct connection to the alarm. The Company has projected commercialization to commence in Canada and Europe in 2021.

Författare Redsense

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.